What's new at Łukasiewicz – PORT?
- Reading time: 3 min.
Can cancer cells exploit strategies known from parasite biology? Dr. Marek Wagner explores melanoma from an evolutionary perspective, highlighting how tumors may manipulate the immune system in ways reminiscent of parasites.
- Reading time: 3 min.
Leading scientists, clinicians, industry representatives, working at the intersection of oncology, neuroscience, and precision medicine will meet at Łukasiewicz – PORT on May 28–29, 2026.
- Reading time: 3 min.
For more than a century, science believed that neurons were responsible for our thoughts, emotions, and memory. During Brain Awareness Week, we tell the story of astrocytes.
- Reading time: 2 min.
We invite you to join a free webinar titled “European Innovation Pathways in Health: Opportunities for MedTech and Biotech Companies,” dedicated to growth and funding opportunities for companies operating in the medical technology and biotechnology sectors.
- Reading time: 5 min.
Glioblastoma is one of the most formidable challenges in modern oncology—a cancer that often evades both conventional treatments and advanced immunotherapies. In the SelCell project, scientists at the Łukasiewicz – PORT are exploring a new strategy based on gamma-delta T lymphocytes. Their goal is to understand why immune cells from some donors can destroy tumor cells far more effectively than those from others.
- Reading time: 3 min.
The WABIO Project has secured over PLN 7 million under the TEAM NET program to develop and validate an integrated biorefinery prototype within the consortium. The work at Łukasiewicz will be led by Prof. Andrzej Białowiec.
- Reading time: 3 min.
On February 24, at the headquarters of the Foundation for Polish Science, we officially launched the implementation of the International Research Agendas (MAB) project within the P4Health Center of Excellence.
- Reading time: 3 min.
February 19 marks Polish Science Day –established on the anniversary of Nicolaus Copernicus’s birth and honoring the achievements of successive generations of researchers. At Łukasiewicz – PORT, we view Polish science within a broad international context.
- Reading time: 3 min.
Thanks to this funding, Dr. Rohit Shrivastava will carry out the AstroExo-HD project, whose aim is to develop new methods for early diagnosis and to identify potential therapeutic targets in Huntington’s disease.
- Reading time: 3 min.
Impairment of blood–brain barrier (BBB) function is among the earliest indicators of neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and vascular dementia. During the seminar, Dr. Mootaz Salman will discuss how inflammation-mediated BBB dysfunction disrupts cerebrovascular integrity and how research aims to prevent irreversible neurodegenerative changes.
